View relevant publications demonstrating the efficacy of ALT-100 mAb in preclinical models Acute Respiratory Distress Syndrome (ARDS) Chorioamnionitis Idiopathic Pulmonary Fibrosis (IPF) Inflammatory Bowel Disease (IBD) NASH Prostate Cancer Pulmonary Hypertension Radiation Induced Lung Injury (RILI) Systemic Lupus Erythematosus – Vasculitis/DAH Trauma-Induced Lung Injury (TILI) Company
